Skip Navigation LinksHome > About Us

Testimonials

I have worked with SMA. for over 10 years on projects worth in excess of $200 million. It is extremely significant that over that 10-year period, the working relationship was always positive, always constructive and that every one of those projects was delivered on budget or under budget, on schedule or ahead of schedule. I think that’s a tremendous accomplishment in this day and age and that it is a reflection of the project management capabilities of SMA.Dr. Randal Chase - Former Senior Vice President, Glaxo Wellcome Inc.

About Us

Canada's leading professional construction project managers 

Since 1986 SMA| METTKO has maintained its independence from design consultants, contractors, suppliers and manufacturers. This independence allows us to provide our clients with the most objective and impartial recommendations without any conflict of interest. Our allegiance is to our clients and their projects.

Our core competencies are Project Management and Construction Management. We can provide technical assistance from inception to completion of any project our clients may have. This means that we can play a pivotal role in determining the user requirements, establishing the budget, plan, organize, implement, monitor and control the project.

In providing these services, we become an extension of our clients' organization, participating in the implementation of their corporate strategies and safe guarding their interests.

Our approach is a holistic one, which results in total control of all aspects of the project and comprehensive project administration.

 SMA| METTKO has two associate companies: SMA Biometics, delivering process engineering and validation solutions, and RCV Solutions providing Regulatory, Compliance, Validation and Training Services for the pharmaceutical and Biotechnology industries.

In the past two decades, SMA| METTKO has gained a solid track record in managing a wide range of industrial type projects with a particular emphasis on pharmaceutical and biotechnology industries.